Radiotherapy: Brightness and darkness in the era of immunotherapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference99 articles.
1. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu. Rev. Pathol.,2021
2. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups;Andrews;Nat. Immunol.,2019
3. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J. Clin. Oncol.,2015
4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Engl. J. Med.,2015
5. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Two-dimensional multifunctional nanosheets as radiosensitizers for chemodynamic/radio-therapy;Colloids and Surfaces B: Biointerfaces;2024-02
2. Making “cold” tumors “hot”- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report;Frontiers in Immunology;2023-12-20
3. Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer;Journal of Cancer Research and Clinical Oncology;2023-11-20
4. The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11
5. Radiotherapy of high-grade gliomas: dealing with a stalemate;Critical Reviews in Oncology/Hematology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3